Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats-Reference-Cited by-同舟云学术

Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats

Published:2000-06 Issue:3 Volume:398 Page:365-374
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Barrett Terrance D,Hayes Eric S,Yong Sandro L,Zolotoy Alexander B,Abraham Shlomo,Walker Michael J.A

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. The ‘Sicilian Gambit’. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms;Anonymous;Eur. Heart J.,1991

2. Better antiarrhythmics? The development of antiarrhythmic drugs selective for ischaemia dependent arrhythmias;Bain;Drug Dev. Res.,1997

3. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias;Barrett;Eur. J. Pharmacol.,1995

4. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ channel blocker;Beatch;Br. J. Pharmacol.,1991

5. Arrhythmias associated with myocardial ischaemia and infarction;Botting;Mol. Aspects Med.,1985

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rat Electrocardiography and General Anesthesia;Cardiovascular Diseases [Working Title];2022-05-07

2. General Anesthesia and Electrocardiographic Parameters in in vivo Experiments Involving Rats;Physiological Research;2022-04-30

3. OCT2013, an ischaemia‐activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine;British Journal of Pharmacology;2022-01-13

4. Surgical and physiological challenges in the development of left and right heart failure in rat models;Heart Failure Reviews;2019-03-22

5. APPLICATION OF VENTRICULAR TACHYARRHYTHMIA DEFINITIONS OF THE UPDATED LAMBETH CONVENTIONS PROVIDES INCOMPATIBILITY WITH EARLIER RESULTS, MASKS ANTIFIBRILLATORY ACTIVITY AND REDUCES INTER-OBSERVER AGREEMENT;J PHYSIOL PHARMACOL;2019